Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jun 11, 2010


John Boyce, co-head of business development, sales, and marketing at Affomix and co-founder of consulting firm Delphi Bio, is among the co-founders of GnuBio, a Harvard University spinout that plans to develop fast and inexpensive microdroplet-based DNA sequencing technology.

Previously, Boyce was head of business development and scientific collaborations at Helicos BioSciences, and before that, he was senior director of commercial development at Parallele Biosciences, now part of Affymetrix, and senior director of sales and marketing at Sequenom.

James Slattery, CEO and founder of Millennium Laboratories, has become a pilot with volunteer, non-profit organization Angel Flight West, which offers free flights to people requiring long-distance travel for the treatment of non-emergency health problems

Slattery has over thirty years as a pilot and served as the state commissioner of aeronautics in Massachusetts for eight years.

Bioanalytical and pharmacokinetic contract research organization MicroConstants announced this week that it has appointed Sam Raees as its new East Coast business development manager.

Raees' "primary goal will be to generate new business with pharmaceutical and biotech companies developing new chemical entities on the East Coast of the United States," the company said in a statement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.